MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 201 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q3 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,950 | -24.5% | 1,495 | -6.2% | 0.00% | – |
| Q2 2023 | $19,813 | -13.5% | 1,594 | -2.4% | 0.00% | – |
| Q1 2023 | $22,892 | -4.8% | 1,634 | -2.8% | 0.00% | – |
| Q4 2022 | $24,055 | -45.3% | 1,681 | -2.3% | 0.00% | – |
| Q3 2022 | $44,000 | -10.2% | 1,720 | +0.4% | 0.00% | – |
| Q2 2022 | $49,000 | -33.8% | 1,714 | -17.8% | 0.00% | – |
| Q1 2022 | $74,000 | -14.9% | 2,084 | +0.0% | 0.00% | – |
| Q4 2021 | $87,000 | -11.2% | 2,083 | +4.5% | 0.00% | -100.0% |
| Q3 2021 | $98,000 | +46.3% | 1,994 | +25.0% | 0.00% | – |
| Q2 2021 | $67,000 | +42.6% | 1,595 | +21.8% | 0.00% | – |
| Q1 2021 | $47,000 | – | 1,310 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $764,690,000 | 24.22% |
| Nekton Capital Ltd. | 1,111,102 | $39,189,000 | 9.66% |
| Pavadi Capital LLC | 133,279 | $4,701,000 | 4.14% |
| Curi Wealth Management, LLC | 420,446 | $14,829,000 | 2.57% |
| Select Equity Group, L.P. | 19,100,056 | $673,659,000 | 2.18% |
| Ownership Capital B.V. | 4,205,521 | $148,329,000 | 1.96% |
| Beck Bode, LLC | 167,969 | $5,924,000 | 1.34% |
| Parkman Healthcare Partners LLC | 77,389 | $2,730,000 | 0.80% |
| STONE RUN CAPITAL, LLC | 55,285 | $1,960,000 | 0.72% |
| Champlain Investment Partners, LLC | 3,582,530 | $126,356,000 | 0.65% |